Apyx Medical Corporation (APYX)

NASDAQ: APYX · Delayed Price · USD
10.49
-0.13 (-1.22%)
At close: Jan 21, 2022 4:00 PM
9.50
-0.99 (-9.44%)
After-hours:Jan 21, 2022 4:52 PM EST
Market Cap360.27M
Revenue (ttm)43.16M
Net Income (ttm)-14.70M
Shares Out34.34M
EPS (ttm)-0.43
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume84,505
Open10.47
Previous Close10.62
Day's Range10.43 - 11.21
52-Week Range8.65 - 17.50
Beta0.87
AnalystsBuy
Price Target18.75 (+78.7%)
Earnings Daten/a

About APYX

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to ac...

IndustryHealth Care Equipment & Supplies
IPO DateJan 1, 1987
CEORobert Gershon
Employees266
Stock ExchangeNASDAQ
Ticker SymbolAPYX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for Apyx Medical stock is "Buy." The 12-month stock price forecast is 18.75, which is an increase of 78.74% from the latest price.

Price Target
$18.75
(78.74% upside)
Analyst Consensus: Buy

News

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

1 week ago - Business Wire

Apyx Medical Corporation Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

2 months ago - Business Wire

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November and December

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

2 months ago - Business Wire

Earnings Preview: Apyx Medical (APYX) Q3 Earnings Expected to Decline

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

4 Breakout Stocks for Impressive Returns

SB, VTSI, FENC and APYX qualified the screen for breakout stocks for today.

Other symbols:FENCSBVTSI
3 months ago - Zacks Investment Research

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2021 Financial Results on November 11, 2021

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

3 months ago - Business Wire

Apyx (APYX) Moves 10.9% Higher: Will This Strength Last?

Apyx (APYX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

3 months ago - Zacks Investment Research

Apyx Medical Corporation to Participate in the Colliers Securities 2021 Institutional Investor Conference

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

4 months ago - Business Wire

Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company's Board of Directors

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

4 months ago - Business Wire

Apyx Medical (APYX) Reports Q2 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 14.29% and 25.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Apyx Medical Corporation Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

5 months ago - Business Wire

Will Apyx Medical (APYX) Report Negative Earnings Next Week? What You Should Know

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

6 months ago - Business Wire

Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

7 months ago - Business Wire

Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

7 months ago - Business Wire

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 0.00% and 9.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

8 months ago - Business Wire

Analysts Estimate Apyx Medical (APYX) to Report a Decline in Earnings: What to Look Out for

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

9 months ago - Business Wire

Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 69.23% and 3.28%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Apyx Medical: Q4 Earnings Insights

Shares of Apyx Medical (NASDAQ:APYX) decreased 2.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 75.00% year over year to ($0.04), which beat th...

9 months ago - Benzinga

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Finan...

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

9 months ago - Business Wire

Apyx Medical's Earnings: A Preview

Apyx Medical (NASDAQ:APYX) announces its next round of earnings this Wednesday, March 31. Here is Benzinga's everything-that-matters guide for this Wednesday's Q4 earnings announcement.

9 months ago - Benzinga

Apyx (APYX) Upgraded to Buy: What Does It Mean for the Stock?

Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

10 months ago - Zacks Investment Research

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 31, 2021

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

11 months ago - Business Wire